Submission Details
| 510(k) Number | K182344 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | August 28, 2018 |
| Decision Date | March 07, 2019 |
| Days to Decision | 191 days |
| Submission Type | Traditional |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
K182344 is an FDA 510(k) clearance for the RhythmAnalytics, a Computer, Diagnostic, Programmable (Class II — Special Controls, product code DQK), submitted by Biofourmis Singapore Pte., Ltd. (Singapore, SG). The FDA issued a Cleared decision on March 7, 2019, 191 days after receiving the submission on August 28, 2018. This device falls under the Cardiovascular review panel. Regulated under 21 CFR 870.1425.
| 510(k) Number | K182344 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | August 28, 2018 |
| Decision Date | March 07, 2019 |
| Days to Decision | 191 days |
| Submission Type | Traditional |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
| Product Code | DQK — Computer, Diagnostic, Programmable |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 870.1425 |